Valore202020212022202320242025TTMSpese di vendita, generali e amministrative22.08 B24.66 B24.77 B21.51 B22.87 B23.68 B23.68 BRicerca e sviluppo12.16 B14.71 B14.6 B483 M1.84 B109 M14.66 BReddito operativo14.67 B18.65 B18.37 B30.43 B31.49 B35.12 B16.82 BProventi non operativi, Totale-3 B-672 M-1.71 B-5.74 B-3.58 B8.01 B8.27 BOneri finanziari, al netto degli interessi capitalizzati201 M183 M276 M772 M755 M971 M971 MProventi non operativi, esclusi gli oneri finanziari-299 M-366 M-114 M123 M363 M-169 M85 MEntrate/uscite straordinarie-2.9 B-489 M-1.87 B-6.63 B-4.69 B7.21 B7.21 BUtile al lordo delle imposte16.5 B22.78 B21.73 B15.06 B16.69 B32.58 B32.58 BQuota di utile———————Imposte1.78 B1.9 B3.78 B1.74 B2.62 B5.78 B5.78 BInteressi di minoranza———————Altri proventi/oneri al netto delle imposte———————Utile netto al lordo delle attività cessate14.71 B20.88 B17.94 B13.33 B14.07 B26.8 B26.8 BAttività cessate———21.83 B00—Utile netto14.71 B20.88 B17.94 B35.15 B14.07 B26.8 B26.8 BRegolazione della diluizione———————Dividendi privilegiati———————Utile netto diluito attribuibile agli azionisti ordinari14.71 B20.88 B17.94 B35.15 B14.07 B26.8 B26.8 BUtile base per azione (EPS base)5.597.936.8313.885.8411.1311.13Utile diluito per azione (EPS diluito)5.517.816.7313.725.7911.0311.03Numero medio di azioni ordinarie in circolazione2.63 B2.63 B2.63 B2.53 B2.41 B2.41 B9.63 BAzioni diluite in circolazione2.67 B2.67 B2.66 B2.56 B2.43 B2.43 B9.7 BEBITDA21.9 B26.04 B25.34 B37.91 B38.83 B42.62 B24.32 BEBIT14.67 B18.65 B18.37 B30.43 B31.49 B35.12 B16.82 BCosto del fatturato28.43 B29.86 B31.09 B26.55 B27.47 B30.26 B30.26 BAltri costi del venduto———————Ammortamento e svalutazione (liquidità)7.23 B7.39 B6.97 B7.49 B7.34 B7.5 B7.5 B
Johnson & Johnson
Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA.
Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings.